Insulinoma surgery: Difference between revisions
Jump to navigation
Jump to search
Line 5: | Line 5: | ||
==Surgery== | ==Surgery== | ||
Surgery is the mainstay of treatment for insulinoma. The feasibility of surgery depends on the stage of insulinoma at diagnosis. | |||
===Benign Tumors=== | ===Benign Tumors=== | ||
*Small well-encapsulated, solitary tumors: | *Small well-encapsulated, solitary tumors: |
Revision as of 15:16, 7 October 2015
Insulinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Insulinoma surgery On the Web |
American Roentgen Ray Society Images of Insulinoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Surgery
Surgery is the mainstay of treatment for insulinoma. The feasibility of surgery depends on the stage of insulinoma at diagnosis.
Benign Tumors
- Small well-encapsulated, solitary tumors:
- Surgical resection is treatment of choice (minimal invasive surgery)
- Enucleation
- Partial pancreatectomy
- Middle pancreatectomy
- Multiple, unencapsulated, >4 cm in diameter, and involves or is near the main pancreatic duct:
- Radical resection
Malignant Tumors
- Resectable tumors:
- Aggressive surgical resection, including extended pancreatic resection, liver resection, and/or liver transplantation
- Post-surgical chemoembolization or radiofrequency ablation of tumors to control hypoglycemia
- Unresectable tumors
- Octreotide administration
- Continous glucose monitoring
- Radiofrequecy ablation
- Embolization
- Intra-arterial chemotherapy